Healthcare News and Headlines
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Healthcare Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HealthcareNewsDistrict Court Vacates FTC Changes to Premerger Notification Rules
District Court Vacates FTC Changes to Premerger Notification Rules
HealthcareLegalM&A

District Court Vacates FTC Changes to Premerger Notification Rules

•February 13, 2026
0
AHA News – American Hospital Association
AHA News – American Hospital Association•Feb 13, 2026

Why It Matters

The ruling curtails the FTC’s ability to broaden HSR filing demands, preserving existing merger reporting thresholds and signaling limits on agency rulemaking authority.

Key Takeaways

  • •FTC rule increased HSR reporting requirements.
  • •Court found FTC exceeded statutory authority.
  • •Chamber of Commerce challenged rule; AHA filed amicus brief.
  • •Decision rejects FTC's reliance on hospital merger study.
  • •Vacated rule may halt future HSR form expansions.

Pulse Analysis

The Hart‑Scott‑Rodino Antitrust Improvements Act has long served as the baseline for pre‑merger notification, requiring companies to disclose basic transaction details before completing a deal. In an effort to modernize the process, the FTC issued a final rule that added granular data fields, aiming to flag potentially anti‑competitive mergers earlier. Proponents argued the enhanced form would improve detection of unlawful consolidations and reduce enforcement costs, but critics warned that the added burden could slow legitimate transactions and strain compliance resources.

The Eastern District of Texas judge, Jeremy D. Kernodle, concluded that the FTC overstepped its legislative mandate. By demanding that the agency prove the rule’s net benefits outweighed its widespread costs—a standard the FTC did not meet—the court found the rule “not necessary and appropriate.” The decision also dismissed the FTC’s reliance on a study of hospital mergers, a point emphasized in the American Hospital Association’s amicus brief. This legal outcome reinforces the principle that agencies must ground major regulatory changes in clear statutory authority and robust cost‑benefit analysis.

For businesses and legal practitioners, the vacated rule restores the status quo, meaning firms can continue using the existing HSR form without the added reporting layers. More broadly, the case serves as a cautionary tale for regulators contemplating expansive rulemaking in antitrust and other domains. It underscores the judiciary’s willingness to scrutinize agency actions that could impose significant compliance costs without demonstrable public benefit, prompting future rule proposals to be more data‑driven and narrowly tailored.

District court vacates FTC changes to premerger notification rules

Article

The U.S. District Court for the Eastern District of Texas Feb. 12 vacated a final rule by the Federal Trade Commission that changed pre‑merger notification rules, form and instructions under the Hart‑Scott‑Rodino Antitrust Improvements Act. The rule had increased reporting requirements on the HSR form. The final rule was challenged by the U.S. Chamber of Commerce in 2024.

“First, the Final Rule exceeds the FTC’s statutory authority because the agency has not shown that the Rule’s claimed benefits will ‘reasonably outweigh’ its significant and widespread costs,” Judge Jeremy D. Kernodle wrote in his opinion. “Though the FTC asserts that the Rule will detect illegal mergers and save agency resources, the FTC fails to substantiate these assertions. The Final Rule is therefore not ‘necessary and appropriate,’ and the statute ‘does not authorize [the FTC] to promulgate [the Final Rule].’”

The AHA filed an amicus brief in the case last year, explaining that the changes made by the FTC under the HSR Act were “unnecessary and unlawful.” Key aspects of yesterday’s decision, including the court’s rejection of the FTC’s reliance on a study regarding hospital mergers, were based on arguments made in the AHA’s amicus brief.

Read Original Article
0

Comments

Want to join the conversation?

Loading comments...